Purchase Order 75P00221P00015
Award Date 12/11/20
Potential Completion Date 12/11/20
Potential Value $232K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Beverly, MA 01915, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services (HHS) awarded a Firm Fixed Price purchase order contract to Qiagen Beverly, LLC, a foreign-owned for-profit manufacturer, for $272,250.00 to provide BioWatch inventory. Qiagen Beverly, LLC has previously received other HHS awards to support the BioWatch program, a nationwide biosurveillance system to detect intentional release of biological agents. The contract does not have a set-aside designation. Additional details on the specific products or...
- The U.S. Department of Health and Human Services (HHS) awarded a $231,000.00 firm-fixed-price purchase order to Qiagen Beverly, LLC, a foreign-owned, for-profit manufacturer, to provide laboratory supplies in support of the BioWatch program. The BioWatch program is a nationwide biosurveillance system operated by HHS to detect the intentional release of aerosolized biological agents. This award is one of several contracts Qiagen Beverly, LLC has received from HHS to support the BioWatch...
- The Department of Health and Human Services (HHS) awarded a $331,000.00 Firm Fixed Price purchase order to Qiagen Beverly, LLC, a foreign-owned, for-profit manufacturer, for the provision of lab supplies. This award is not associated with any set-aside designation. Qiagen Beverly, LLC has previously received awards from HHS and the Department of the Air Force Materiel Command to provide products and services in support of the BioWatch program, a nationwide biosurveillance system to detect the...
- This firm-fixed price purchase order was awarded by the U.S. Department of Health and Human Services (HHS) to Qiagen Beverly, LLC, a foreign-owned, for-profit manufacturer, to provide laboratory supplies, testing components, and other products to support biosurveillance and COVID-19 testing efforts. The contract has a ceiling value of $165,918.73 and a completion date of March 12, 2018. It does not utilize any set-aside designations. Qiagen Beverly has received similar prime contracts from HHS...
- This $158,946.49 firm-fixed price purchase order was awarded by the Department of Health and Human Services (HHS) to Qiagen Beverly, LLC, a division of the multinational biotechnology company Qiagen N.V. The contract is for the provision of laboratory supplies, which are likely to support HHS's biosurveillance and COVID-19 testing efforts, such as the BioWatch program operated by HHS. Qiagen Beverly has received several previous awards from HHS and the Department of the Air Force to supply...
- This is a firm-fixed price purchase order awarded by the Department of Health and Human Services (HHS) to Qiagen Beverly, LLC, a division of the parent company Qiagen N.V. The contract, valued at $165,155.23, is for the supply of laboratory supplies to support biosurveillance and COVID-19 testing efforts. Qiagen Beverly primarily provides products to the BioWatch program, a nationwide biosurveillance system operated by HHS to detect the intentional release of biological agents. The company has...
- This federal contract award was made by the Office of the Chief Operating Officer, a civilian agency, to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, scientific equipment, and bioinformatics solutions. The $14,003.16 fixed-price contract is a Blanket Purchase Agreement (BPA) call with a completion date of March 24, 2015. Qiagen, LLC is a division of the international biotechnology company Qiagen N.V. and has established itself as a critical supplier of advanced...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $55,000.00 firm fixed price purchase order contract to Qiagen, LLC, a division of Qiagen N.V., an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics. This contract has a completion date of May 21, 2024. Qiagen is a foreign-owned, for-profit manufacturer that has provided a range of products and services to support federal...
- This is a federal contract award to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract, valued at $14,663.49, is a Blanket Purchase Agreement (BPA) Call with a firm fixed price. The ultimate completion date is March 24, 2015. The contract was awarded by the Office of the Chief Operating Officer, a civilian agency, and does not have a set-aside designation. Qiagen, LLC is a foreign-owned, for-profit manufacturer of molecular diagnostics, scientific...
- On April 14, 2015, the Office of Logistics and Acquisition Operations awarded a Blanket Purchase Agreement (BPA) call to Qiagen, LLC, a foreign-owned molecular diagnostics manufacturer headquartered in Germantown, Maryland. This firm fixed-price contract, valued at $15,138.84, procures chemicals to support federal operations, with performance conducted at the company's facility in Valencia, California. The award was made without a set-aside designation, reflecting Qiagen's competitive standing...